MYT1, also known as Myelin transcription factor 1, consists of a long 1,121 amino acid isoform that is 122 kDa, and is involved in the development of the central nervous system and the regulation of oligodendrocyte lineage development. Current research is being conducted on the relationship between MYT1 and a variety of diseases and disorders, including multiple sclerosis, papillary thyroid carcinoma, leukomalacia, neuronitis, sporadic breast cancer, skin cancer, pancreatitis, schizophrenia, thyroiditis, and carcinoma. The protein interacts with SIN3B, PIN1, PLK1, HDAC1, and CDK1, and has been linked to pancreatic and breast cancer pathways, as well as G1 to S cell cycle control.

Long Name

Myelin transcription factor 1

Alternate Names

KIAA0835, KIAA1050, MTF1, MyTI, PLPB1

Gene Symbol

MYT1

Additional Myt1 Products

Product Documents for Myt1 Antibody [Janelia Fluor® 549]

Product Datasheets

Download Product Datasheets

COA

SDS

Download SDS

Product Specific Notices for Myt1 Antibody [Janelia Fluor® 549]

Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Citations
Reviews

Myt1 Antibody [Janelia Fluor® 549]

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-99008JF549

Key Product Details

Species Reactivity

Applications

Label

Antibody Source

Concentration

View all Myt1 Antibodies »

Product Specifications

Immunogen

Clonality

Host

Isotype

Applications for Myt1 Antibody [Janelia Fluor® 549]

Immunohistochemistry-Paraffin

Formulation, Preparation, and Storage

Purification

Formulation

Preservative

Concentration

Shipping

Stability & Storage

Background: Myt1